SelectScience InterviewsLife Sciences

Assay Development for Screening of Therapeutic Transglutaminase Inhibitors

26 May 2016
Assay Development for Screening of Therapeutic Transglutaminase Inhibitors

Dr Andreas Heil, research scientist at Zedira GmbH, describes how BMG Labtech's CLARIOstar® is used to screen inhibitors of transglutaminases for therapeutic applications, such as coeliac disease.

Other videos from SelectScience

Links